University of Cologne | MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Browse and search for drug monographs and related information

Approved pharmaceutical products by global regulatory authorities

Explore a comprehensive list of organizations, including their profiles and details

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 407 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "University of Cologne"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

A Multicenter, Randomized, Controlled Study to Assess Mitral vAlve reconsTrucTion for advancEd Insufficiency of Functional or iscHemic ORigiN

Not Applicable

Conditions: Mitral Valve Insufficiency

Interventions: Device: MitraClip system (Abbott Vascular, Menlo Park, USA)
Procedure: Mitral valve surgery

First Posted Date: 2015-02-25

Last Posted Date: 2017-08-01

Lead Sponsor: Universitätsklinikum Köln

Target Recruit Count: 210

Registration Number: NCT02371512

Locations: 🇩🇪
Heart Center University of Cologne, Cologne, Germany

NovaTears® Eye Drops Observational Study NT-003

Completed

Conditions: Dry Eye Syndromes

Interventions: Device: NovaTears® Eye Drops

First Posted Date: 2015-02-05

Last Posted Date: 2016-03-09

Lead Sponsor: Novaliq GmbH

Target Recruit Count: 25

Registration Number: NCT02356328

Locations: 🇩🇪
University Eye Hospital Freiburg, Freiburg, Germany
🇩🇪
Department of Ophthalmology, University of Cologne, Cologne, Germany

GHSG-AFM13 An Open-label, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma

Phase 2

Completed

Conditions: Hodgkin Lymphoma

Interventions: Drug: AFM13

First Posted Date: 2014-12-22

Last Posted Date: 2020-11-13

Lead Sponsor: University of Cologne

Target Recruit Count: 23

Registration Number: NCT02321592

Locations: 🇩🇪
1st Department of Medicine, Cologne University Hospital, Cologne, Germany

Influence of Triathlon on the Electrolyte Balance

Completed

Conditions: Hyponatremia

First Posted Date: 2014-10-13

Last Posted Date: 2015-05-05

Lead Sponsor: University Hospital of Cologne

Target Recruit Count: 1089

Registration Number: NCT02263586

Locations: 🇩🇪
Uniklinik Köln, Köln, NRW, Germany

Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome

Completed

Conditions: Cardiac Arrest

First Posted Date: 2014-09-25

Last Posted Date: 2020-11-04

Lead Sponsor: Universitätsklinikum Köln

Target Recruit Count: 20

Registration Number: NCT02247947

Locations: 🇩🇪
University Hospital of Cologne, Cologne, NRW, Germany

Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis

Phase 2

Completed

Conditions: Mycoses
Candidiasis, Invasive
Candidemia

Interventions: Drug: SCY-078
Drug: Fluconazole
Drug: Micafungin

First Posted Date: 2014-09-19

Last Posted Date: 2024-06-25

Lead Sponsor: Scynexis, Inc.

Target Recruit Count: 27

Registration Number: NCT02244606

Locations: 🇺🇸
University of Texas Health Science Center at Houston, Houston, Texas, United States
🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
South Texas Veterans Healthcare System, San Antonio, Texas, United States

and more 27 locations

Characterization of Neuropsychologic and Physical Performance in Geriatric Patients With Hyponatremia.

Completed

Conditions: Hyponatremia

Interventions: Other: Multidimensional Geriatric Assessment (MGA)

First Posted Date: 2014-09-17

Last Posted Date: 2019-08-09

Lead Sponsor: Volker Burst

Target Recruit Count: 100

Registration Number: NCT02242604

Locations: 🇩🇪
Department for Geriatric Medicine - University of Cologne, Cologne, Germany

Quantification of Transition Metals

Conditions: Neurodegenerative Diseases
Infections

First Posted Date: 2014-08-21

Last Posted Date: 2014-08-21

Lead Sponsor: University of Cologne

Target Recruit Count: 3000

Registration Number: NCT02222779

Locations: 🇩🇪
Department of Pharmacology, Cologne, Northrhine Westphalia, Germany

Clinical Impact of Cytokine in Cardiac Surgery

Conditions: Coronary Disease

First Posted Date: 2014-08-12

Last Posted Date: 2017-07-12

Lead Sponsor: University Hospital of Cologne

Target Recruit Count: 300

Registration Number: NCT02213939

Locations: 🇩🇪
University Hospital of Cologne; Department of Cardiothoracic Surgery, Cologne, Germany

Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma

Phase 2

Completed

Conditions: Hodgkin Lymphoma

Interventions: Drug: B-CAP
Drug: Brentuximab Vedotin

First Posted Date: 2014-07-16

Last Posted Date: 2024-08-23

Lead Sponsor: University of Cologne

Target Recruit Count: 70

Registration Number: NCT02191930

Locations: 🇩🇪
1st Dept. of Medicine, Cologne University Hospital, Cologne, Germany

Prev
1
19
20
21
22
23
41
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy